期刊文献+

IgA与过敏性紫癜发病关系的研究进展 被引量:9

Progress in IgA and the pathogenesis of Henoch-Schonlein purpura
原文传递
导出
摘要 IgA在过敏性紫癜(HSP)发病过程中起重要作用,目前研究显示HSP以IgA(主要是IgA1)在皮肤小血管壁和肾小球沉积为特征,而IgA1糖基化的水平降低.这种异常糖基化IgA1由于易于自身聚集,不易被肝细胞去唾液酸糖蛋白受体清除,削弱了补体清除免疫复合物的能力,以及暴露了新表位等原因,导致IgA1免疫复合物形成而沉积在皮肤血管壁及肾小球,主要经旁路途径激活补体,引起炎症损伤.此外,抗内皮细胞抗体、抗心磷脂抗体、抗中性粒细胞胞质抗体等各种IgA自身抗体也参与HSP的组织损伤过程. IgA plays an important role in the course of Henoch-Schonlein purpura.The current study shows that the HSP is characterized by IgA principally IgA1) depositions in the wall of dermal vessel and the renal mesangium, and IgA1 is deficient in galactose. IgA1 with aberrant glycosylation has a tendency to be self-aggregated, not to be efficiently cleared by the hepatic asialoglycoprotein receptor. It also weakens the ability of complement to remove immune complexes, and causes the exposure of new epitope and so on. All these lead to the formation of IgA1 immune complexes and the deposition in the wall of dermal vessel and the renal mesangium. IgA1 immune complexes activate complement principally through the alternative pathway, which causes inflammatory injury. In addition, various IgA autoantibodies, such as anti-endothelial cell antibodies,anticardiolipin antibodies and anti-neutrophil cytoplasmic antibodies, are also involved in the process of tissue damage of Henoch-Schonlein purpura.
出处 《国际儿科学杂志》 2010年第5期478-480,共3页 International Journal of Pediatrics
关键词 过敏性紫癜 糖基化 IGA IGA Purpura,Henoch-Schonlein Glycosylation IgA IgA1
  • 相关文献

参考文献3

二级参考文献23

  • 1王自良,张爱平.CD71与IgA肾病发病机制的探讨[J].国外医学(泌尿系统分册),2004,24(5):708-711. 被引量:7
  • 2鲍浩,黎磊石,刘志红,孙骅,张馨,陈惠萍,曾彩虹,郑春霞.不同类型IgA肾病的临床病理比较[J].肾脏病与透析肾移植杂志,2006,15(5):409-415. 被引量:35
  • 3甘波 李献珍 曾明辉.过敏性紫癜肾损害临床相关因素的探讨[J].中华肾脏病杂志,1999,15(1):51-52. 被引量:6
  • 4于立志,王鸿利.过敏性紫癜、紫癜性肾炎.见:董德长.实用肾脏病学.上海:上海科技出版社,1999.1097-1104. 被引量:2
  • 5Ronald J, Jennette JC, Patrick H. Primary glomerular disease// Barry MB. The Kidney. Harcout: Asia W.B Saunders, 1999: 1302-1310. 被引量:1
  • 6Moura IC, Centelles MN, Arcos-Fajardo M, et al. Identification of the transferring receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp, 2001, 194: 417-425. 被引量:1
  • 7Haddad E, Moura IC, Arcos-Fajardo M, et al. Enhanced expression of the CDT1 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephitis: association between CDT1 expression and IgA deposits. J Am Soc Nephrol, 2003, 14: 327-337. 被引量:1
  • 8Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international comsensus conference. Arthritis Rheum, 1994, 37(2): 187-192. 被引量:1
  • 9Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of HenochSchonlein purpura. Arthritis Rheum, 1990, 33 (8): 1114-1121. 被引量:1
  • 10Wang Y, Zhao MH, Zhang YK, et al. Binding capacity and pathophysiological effects of IgAl from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol, 2004, 136( 1 ): 168-175. 被引量:1

共引文献30

同被引文献127

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部